Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

Uber Black To Double Fleet Size In 2026, Expands Premium Rides Across Delhi, Mumbai And Bengaluru
Uber Black To Double Fleet Size In 2026, Expands Premium Rides Across Delhi, Mumbai And Bengaluru
World Economic Forum 2026 Davos: MMRDA Signs 12 MoUs, Secures USD 104.65 Billion In Foreign Direct...
World Economic Forum 2026 Davos: MMRDA Signs 12 MoUs, Secures USD 104.65 Billion In Foreign Direct...
Embraer’s Commercial Aircraft To Take Centre Stage At Wings India 2026; Company To Propose...
Embraer’s Commercial Aircraft To Take Centre Stage At Wings India 2026; Company To Propose...
Mumbai Real Estate News: Inorbit Acquires Nadir Company; Heritage Capitol Cinema Building To Undergo...
Mumbai Real Estate News: Inorbit Acquires Nadir Company; Heritage Capitol Cinema Building To Undergo...
Union Budget 2026–27: Infrastructure And Energy Firms Seek Policy Streamlining, Green Push To...
Union Budget 2026–27: Infrastructure And Energy Firms Seek Policy Streamlining, Green Push To...